PubmedID,Title,Date,Authors,Affiliations,Email
40616323,Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy: The ANGEL-TNK Randomized Clinical Trial.,2025,"Yuesong Pan, Xingquan Zhao, Jing Jing, Yunyun Xiong, Zixiao Li, Yilong Wang, Yongjun Wang, Liping Liu","China National Clinical Research Center for Neurological Diseases, Beijing, Beijing, China.",N/A
40608836,Detecting soil-transmitted helminth and Schistosoma mansoni eggs in Kato-Katz stool smear microscopy images: A comprehensive in- and out-of-distribution evaluation of YOLOv7 variants.,2025,Peter Kenneth Ward,"Enaiblers AB, Uppsala, Sweden.",N/A
40602346,Pseudomonas aeruginosa vaccine identified by the AI-immunology™ platform improves outcomes in a murine biofilm lung infection model.,2025,"Andreas Holm Mattsson, Pär Comstedt","Evaxion Biotech, Dr Neergaards vej 5F, 2970 Hørsholm, Denmark.",N/A
40598566,"Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study results.",2025,"Meena Okera, Nicole McCarthy, Morena Shaw, Margaret Tonda, Mark Shilkrut","Cancer Research SA, Adelaide, SA, Australia.; ICON Cancer Centre, Auchenflower, QLD, Australia.; Olema Oncology, San Francisco, CA, USA.",N/A
40588561,Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer.,2025,"Javier Cibella, Clelia Peano","Human Technopole, Milan, Italy.",N/A
40588371,Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort.,2025,"Sandip Pravin Patel, Anup Kasi, Mark Walshauser, Christine M Magner, Megan Othus, Christopher W Ryan, Charles Blanke","OHSU, Portland, Oregon, USA.; UC San Diego Health Moores Cancer Center, La Jolla, California, USA spatel@ucsd.edu.; SWOG, San Antonio, Texas, USA.; Cancer Care Center of O'Fallon, O'Fallon, Illinois, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; KUMC, Kansas City, Kansas, USA.",spatel@ucsd.edu
40562770,Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.,2025,"Danai Dima, Mariola A Vazquez-Martinez, Utkarsh Goel, Aimaz Afrough, Aishwarya Sannareddy, Oren Pasvolsky, Jack Khouri, Ariel Grajales-Cruz, Mahmoud R Gaballa, Gabriel De Avila, Shahzad Raza, Megan M Herr, Tiffany Richards, Gurbakhash Kaur, Omar Castaneda Puglianini, Yi Lin, Kenneth H Shain, Doris K Hansen, Krina K Patel, Larry D Anderson, Hans C Lee, Faiz Anwer","Moffitt Cancer Center, Tampa, FL, USA.; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA. ddima@fredhutch.org.; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.; Mayo Clinic, Rochester, MN, USA.; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; MD Anderson Cancer Center, Houston, TX, USA.",ddima@fredhutch.org
40559746,Development of an Immunochromatographic Test with Recombinant MIC2-MIC3 Fusion Protein for Serological Detection of ,2025,"Jicheng Qiu, Xialin Ma, Xiaojie Wu, Xiaoguang Li","Hangzhou Evegen Biotech Co., Ltd., Hangzhou 310018, China.; Beijing Yuanda Xinghuo Medicine Technology Co., Ltd., Beijing 102615, China.",N/A
40536197,Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application.,2025,"Yuhua Shang, Tengchuan Jin","Anhui Genebiol Biotech. Ltd., Hefei, Anhui, China.",N/A
40526051,"Artificial intelligence, machine learning, and digitalization systems in the cell and gene therapy sector: a guidance document from the ISCT industry committees.",2025,"Vincenzo Di Cerbo, Sean J Hart, Rukmini Ladi, Shanya Jiang, Abeer Madbouly, Lydia Redmond, Simone Stickland, Anand Srinivasan, Keara Trinkle, Anthony Ting, Shannon S Eaker, Dalip Sethi","Ori Biotech, Philadelphia, Pennsylvania, USA.; Terumo Blood and Cell Technologies, Inc., Lakewood, Colorado, USA. Electronic address: dalip.sethi@terumobct.com.; CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, Minnesota, USA.; Xcell Biosciences Inc, San Francisco, California, USA.; LumaCyte, Inc., Charlottesville, Virginia, USA.; Cell and Gene Therapy Catapult, London, UK.; BioBridge Global, San Antonio, Texas, USA.; Sartorius Stedim North America Inc., Bohemia, New York, USA.; Sartorius Stedim North America Inc., Ann Arbor, Michigan USA.; ISCT, Vancouver, BC, Canada.; BRL C&GT Consulting, LLC, Shaker Heights, Ohio, USA.",dalip.sethi@terumobct.com
40514065,Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysis.,2025,"David Andreu-Sanz, Lisa Gregor, Emanuele Carlini, Sebastian Kobold","Division of Clinical Pharmacology, LMU Klinikum, Member of the German Center for Lung Research (DZL), Munich, Germany.; Division of Clinical Pharmacology, LMU Klinikum, Member of the German Center for Lung Research (DZL), Munich, Germany sebastian.kobold@med.uni-muenchen.de.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München - German Research Center for Environmental Health Neuherberg, Munich, Germany.",sebastian.kobold@med.uni-muenchen.de
40513575,CSF1R,2025,"Herrad Baurmann, Werner Müller","Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.",N/A
40513573,Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.,2025,"Benoit Rousseau, Mitesh Patel, Oliver Artz, Shrey Patel, Omar Hayatt, Guillem Argilés, Michael B Foote, Lingqi Luo, Rachna Shah, Shub Mehta, Karthik Rangavajhula, Drew Gerber, Rohini Bhattacharya, Dennis Stephens, David Mieles, Violaine Randrian, Somer Abdelfattah, Lin Zhang, Nathalie Membreno-Berganza, Michelle F Lamendola-Essel, Florence Piastra-Facon, Paul Johannet, Steve Lu, James R White, Steven B Maron, Afsar Barlas, Caroline M Weipert, Eric Rosiek, Rui Qu, Deborah Fidele, Sydney Bowker, Alec Kahn, Xiaoxiao Ma, Andrea Cercek, Elisa de Stanchina, Neil H Segal, Luis A Diaz","Guardant Health, Inc., Palo Alto, CA, USA.; Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: diazl5@mskcc.org.; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.; Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Boehringer Ingelheim Inc., Ridgefield, CT, USA.; Molecular Cytology Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Resphera Biosciences, Baltimore, MD, USA.",diazl5@mskcc.org
40506731,Incorporating automation in a cytogenetics laboratory: three practitioners' perspectives on benefits and limitations.,2025,Jennie Thurston,"Cytogenetics and Molecular Pathology, Atrium Health and CPG Pathology, Charlotte, NC, USA.",N/A
40506515,Author Correction: Proteolysis-targeting influenza vaccine strains induce broad-spectrum immunity and in vivo protection.,2025,"Haiqing Bai, Lei Yan, Hanhui Hong, Xin Xie","Beijing Daxiang Biotech, Beijing, China.; Henan Academy of Innovations in Medical Science, Zhengzhou, China.; Xellar Biosystems, Boston, MA, USA.; AccuraMed Technology, Guangzhou, China.",N/A
40506221,Minimizing human-induced variability in quantitative angiography for a robust and explainable AI-based occlusion prediction in flow diverter-treated aneurysms.,2025,"Mohammad Mahdi Shiraz Bhurwani, Jason M Davies, Ciprian N Ionita","QAS.AI Inc, Buffalo, NY, USA.",N/A
40494072,AI-chemometric assisted real-time monitoring of tryptophan fermentation process using a sensor fusion strategy.,2025,"Huihui Jia, Ying Wang, Chao Gai","Channel Biotech Co., Ltd., Innovation R&D Center, Jinan, Shandong 250012, China.; Dongying XINGSHENG Special Equipment Technology Co., Ltd., Dongying, Shandong 257000, China.",N/A
40484157,The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus report.,2025,"Maria Grazia Razeti, Giampaolo Bianchini, Michele Caruso, Saverio Cinieri, Carmine De Angelis, Michelino De Laurentis, Alessandra Fabi, Ida Paris, Giancarlo Pruneri, Claudio Zamagni","Precision Medicine Unit in Senology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy.; Humanitas Istituto Clinico Catanese, Catania, Italy.; Division of Medical Oncology, Breast Unit, Ospedale Perrino, Brindisi, Italy.; U.O.C. Clinica Di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Napoli, Italy.; IRCCS Azienda Ospedaliero-universitaria di Bologna, Italy.",N/A
40473950,Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.,2025,"Kelsey R Monson, Robert Ferguson, Joanna E Handzlik, Leah Morales, Jiahan Xiong, Vylyny Chat, Sasha Dagayev, Danny Simpson, Esther Kazlow, Anabelle Bunis, Chaitra Sreenivasaiah, Milad Ibrahim, Iryna Voloshyna, Mariaelena Capone, Gabriele Madonna, Yuting Lu, Yongzhao Shao, Anna Pavlick, Michelle Krogsgaard, Janice Mehnert, Hao Tang, Sonia Dolfi, Daniel Tenney, John B A G Haanen, Igor Puzanov, Michael Postow, Jason J Luke, Paolo A Ascierto, Iman Osman, Tomas Kirchhoff","Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY, USA.; Bristol Myers Squibb Corp, Princeton, NJ, USA.; Medical Oncology, Antoni van Leeuwenhoek Nederlands Kanker Instituut, Amsterdam, the Netherlands.; Department of Medicine, NYU Langone Health, New York, NY, USA.; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Melanoma Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA. tomas.kirchhoff@nyulangone.org.; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, NY, USA.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, NY, USA. tomas.kirchhoff@nyulangone.org.; Departments of Population Health and Environmental Medicine, NYU Langone Health, New York, NY, USA.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, NY, USA. tomas.kirchhoff@nyulangone.org.; The Interdisciplinary Melanoma Cooperative Group, NYU Langone Health, New York, NY, USA.; New York Genome Center, New York, NY, USA.; Division of Hematology & Medical Oncology, the Cutaneous Oncology Program, Weill Cornell, New York, NY, USA.",tomas.kirchhoff@nyulangone.org
40473445,"Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study.",2025,"Elena Elimova, Crystal S Denlinger, Bruce Lin, Lin Yang, Mark A Ozog, Phillip M Garfin, Geoffrey Ku","Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Jazz Pharmaceuticals, Palo Alto, CA, USA.; Department of Gastrointestinal Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.; Section of Hematology-Oncology, Virginia Mason Medical Center, Seattle, WA, USA.; Department of Gastrointestinal Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada. Electronic address: elena.elimova@uhn.ca.",elena.elimova@uhn.ca
40465294,Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders.,2025,"Frank Aboubakar-Nana, Alexandra Johnson, Anna C Olsson-Brown, Andrea Malgeri, Alessio Cortellini, Aditi Singh, Kaushal Parikh","Department of Oncology, Mayo Clinic, Rochester, Minnesota.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.; Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, United Kingdom.; Fondazione Policlinico Universitario Campus-Biomedico, Roma, Italy.; Service de Pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium.",N/A
40455815,"rechARge: a randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator's choice in patients with mCRPC.",2025,"Kim Nguyen Chi, Neal D Shore, Teresa Cascella, Irina Irincheeva, Stephanie Kreiser, Antoine Thiery-Vuillemin, Dana E Rathkopf","Department of Research and Development, Bristol Myers Squibb, Boudry, Switzerland.; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Urology, Carolina Urologic Research Center/AUC Urology Specialists, Myrtle Beach, SC, USA.; Department of Clinical Science, Bristol Myers Squibb, Princeton, NJ, USA.; Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada.",N/A
40449107,Research note: Genetic parameters estimation of egg quality traits in Beijing-You chickens.,2025,"Yuze Yang, Zhuo Chang","Beijing General Station of Animal Husbandry, Beijing 100107, China.",N/A
40447318,Neovascular pruning by IDO1 inhibitors can potentiate immunogenic cytotoxicity of ischemia-targeted agents to synergistically enhance anti-PD-1 responsiveness.,2025,"Souvik Dey, Maurice T Hampton","Telesis Therapeutics, Inc, Philadelphia, Pennsylvania, USA.; WuXi Advanced Therapies, Philadelphia, Pennsylvania, USA.",N/A
40447316,"Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors.",2025,"Alia D Zander, Rossin Erbe, Yan Liu, Ailin Jin, Seung Won Hyun, Sayantoni Mukhopadhyay, Ben Terdich, Mario G Rosasco, Nirali Patel, Brett M Mahon, A Kate Sasser, Michelle A Ting-Lin, Halla Nimeiri, Justin Guinney, Douglas Adkins, Matthew Zibelman, Kyle A Beauchamp, Chithra Sangli, Michelle M Stein, Timothy Taxter, Timothy Chan, Sandip P Patel, Ezra E W Cohen","Tempus AI Inc, Chicago, Illinois, USA ezra.cohen@tempus.com.; UCSD Moores Cancer Center, La Jolla, California, USA.; Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Tempus AI Inc, Chicago, Illinois, USA.; Center for Immunotherapy and Precision Immuno-oncology, Cleveland Clinic, Cleveland, Ohio, USA.; Washington Univ, St. Louis, Missouri, USA.",ezra.cohen@tempus.com
40444085,Corrigendum: Development and validation of nomogram models for predicting immune-related adverse events in recurrent and metastatic nasopharyngeal carcinoma patients treated with PD-L1 inhibitors.,2025,"Junyou Ge, Yan Qing, Youneng Wei","Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd., Chengdu, China.",N/A
40441146,Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease.,2025,"Alexandre Louvet, Philippe Mathurin","Service des Maladies de L'appareil Digestif et Unité INFINITE 1286, Hôpital Huriez, Lille, France.",N/A
40439959,Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer.,2025,"Benjamin Lowentritt, Ibrahim Khilfeh, Carmine Rossi, Shawn Du, Frederic Kinkead, Lilian Diaz, Dominic Pilon, Lorie Ellis, Neal D Shore","Analysis Group, Inc., Montréal, QC, Canada.; Chesapeake Urology, Towson, MD, USA.; Johnson & Johnson, Horsham, PA, USA.; START Carolinas/Carolina Urologic Research Center, 823 82nd Parkway, Myrtle Beach, SC, 29572, USA. nshore@auclinics.com.",nshore@auclinics.com
40425996,"First-in-line subcutaneous injectable for reversible, non-hormonal male contraception.",2025,"Katherine G Hamil, Michael G O'Rand","Eppin Pharma Inc, Chapel Hill, NC, USA.",N/A
40422786,Identification of TRPV1-Inhibitory Peptides from ,2025,Kang Chen,"Mimask (Xiamen) Bio-Tech Co., Ltd., Xiamen 361000, China.",N/A
40405265,Novel fully human high-affinity anti-TREM2 antibody shows efficacy in clinically relevant Alzheimer´s mouse model.,2025,"Markus Kraller, Julia Faßbender, Ammar Jabali, Joseph Kroeger, Barbara Fink, Bastian Popper, Martin Ungerer, Miriam A Christlmeier","ISAR Bioscience GmbH, 82152, Planegg, Germany. Martin.Ungerer@isarbioscience.de.; ISAR Bioscience GmbH, 82152, Planegg, Germany.; Biomedical Center, Medical Faculty, Core Facility Animal Models, LMU Munich, 82151, Planegg-Martinsried, Germany.; ISAR Bioscience GmbH, 82152, Planegg, Germany. Miriam.Christlmeier@isarbioscience.de.",Miriam.Christlmeier@isarbioscience.de
40403500,"Design, synthesis, and biological evaluation of novel 2-substituted aniline pyrimidine derivatives as potential and orally bioavailable Mer inhibitors with antitumor activities.",2025,Yanbo Wang,"Shijiazhuang Vortech Biotech Co., Ltd., Shijiazhuang 050051, China.",N/A
40403207,"Palbociclib, a Selective CDK4/6 Inhibitor, Administered Before and After Chemoradiotherapy for Human Papillomavirus-Negative, Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm, Phase II Trial.",2025,"Peter J Oppelt, Sidharth V Puram, Ryan S Jackson, Randall C Paniello, Jason T Rich, Patrik Pipkorn, Wade L Thorstad, Douglas R Adkins","Alvin J. Siteman Cancer Center, St Louis, MO.; The Robert Ebert and Greg Stubblefield Head and Neck Tumor Center at Siteman, St Louis, MO.",N/A
40399555,Genome-wide association study of long COVID.,2025,"Tomoko Nakanishi, Beatriz Cortés, Heath E O'Brien, Ana Ochoa-Guzman, Alicia Huerta-Chagoya, Nasa Sinnott-Armstrong, Elizabeth T Cirulli, Amit K Maiti, Daniel C Posner, Francesca Minnai, C A Robert Warmerdam, Raimonds Rešcenko, Lorenzo Miano, Laura Carvajal-Silva, Kevin Aguilar-Valdés, Ekaterina Vergasova, Pasquale Striano, Hajar Fauzan Ahmad, Shiuh-Wen Luoh, Alicia Colombo, Patrick J Short, Laura Ansone, Luca V C Valenti, Ricardo A Verdugo, Lude H Franke, Alexander Rakitko, Emma L Duncan, Alessandra Renieri, Rafael de Cid, Teresa Tusié-Luna, J Brent Richards","Genotek Ltd, Moscow, Russia.; Grup de REcerca en Impacte de les Malalties Cròniques i les seves Trajectòries (GRIMTra), Barcelona, Spain.; Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.; Latvian Biomedical Research and Study Centre, Riga, Latvia.; Department of Genetics and Genomics, Mydnavar, Southfield, MI, USA.; Departamento de Anatomía Patológica, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Sano Genetics Limited, London, UK.; Departamento de Oncología Básico Clínica, Facultad de Medicina, Universidad de Chile, Santiago, Chile.; Genetica Medica, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.; VA Boston Healthcare System, Boston, MA, USA.; 5 Prime Sciences Inc, Montreal, Quebec, Canada.; IRCCS G Gaslini, Genoa, Italy.; Department of Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Instituto de Investigaciones Biomédicas, UNAM, Mexico City, Mexico.; Unidad de Biología Molecular y Medicina Genómica, Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.; Faculty of Industrial Sciences and Technology, Universiti Malaysia Pahang Al Sultan Abdullah, Pahang, Malaysia.; Oncode Investigator, Utrecht, the Netherlands.; Research Fellow, Japan Society for the Promotion of Science, Tokyo, Japan.; Unidad de Biología Molecular y Medicina Genómica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Herbold Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Helix, San Mateo, CA, USA.; Università degli Studi di Milano, Milan, Italy.; Instituto de Investigación Interdisciplinaria y Facultad de Medicina, Universidad de Talca, Talca, Chile.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.; VA Portland Health Care System, Portland, Portland, OR, USA.; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.; Department of Medical Biotechnology and Translational Medicine (BioMeTra), Università degli Studi di Milano, Milan, Italy.",N/A
40399553,Heart failure with preserved ejection fraction therapeutics: in search of the pillars.,2025,"Abdelghani El Rafei, Josephine A Harrington, Andrew P Ambrosy, Marc P Bonaca, Mario Enrico Canonico","Department of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.; Division of Research, Kaiser Permanente Northern California, Pleasanton, CA, USA.; Colorado Prevention Center, Aurora, CO, USA.; Colorado Prevention Center, Aurora, CO, USA. abdelghani.elrafei@cuanschutz.edu.",abdelghani.elrafei@cuanschutz.edu
40398558,Prediction Pathway for Severe Asthma Exacerbations: A Bayesian Network Analysis.,2025,"Carlos A Torres-Duque, Saraid Cerda","CINEUMO, Respiratory Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia.; Medical Specialties Unit, Secretary of National Defense, Mexico City, Mexico.",N/A
40393983,PKMYT1 kinase ameliorates cisplatin sensitivity in osteosarcoma.,2025,Zheng Fu,"Xinyi Biotech Co., Ltd, Lingang, Shanghai, 201306, PR China.",N/A
40389374,Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial.,2025,"Jason J Luke, Katherine Bever, Janis Taube, Ashish Massey, David Yao, Jaclyn Neely, Rachel Tam, George Lee, Akshita Gupta, Santanu Dutta, Peter Szabo, Riyue Bao, Tim Reilly","UPMC, Pittsburgh, Pennsylvania, USA.; UPMC, Pittsburgh, Pennsylvania, USA lukejj@upmc.edu.; Bristol Myers Squibb, Princeton, New Jersey, USA.; Johns Hopkins, Baltimore, Maryland, USA.",lukejj@upmc.edu
40382524,The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study.,2025,"Amanda G Paulovich, Stephen McMorn, Lenka Oplustil O'Connor, Benedetta Lombardi, Paola Marco-Casanova, Eric T Gangl, Bharat Patel, Mark J O'Connor, Emma Dean, Roman Zviezdin","Oncology R&D, AstraZeneca, Cambridge, UK.; Clinical Pharmacology and Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.",N/A
40376501,China's Malaria R&D Innovations: A Scoping Review from 2013-2023.,2025,"Wei Ding, Sandra Perez, Roger Frutos, Chunsheng Ye, Danna Wu, Xiaoxiao Jiang Kwete, Yuan Sui","Hangzhou Biotest Biotech Co., Ltd., Hangzhou City, Zhejiang Province, China.; Faculty of Vocational Studies, Universitas Airlangga, Surabaya, Indonesia.; Université Côte d'Azur, ESPACE UMR 7300, Nice, France.; Global Health Research and Consulting, Yangzhou City, Jiangsu Province, China.; Intertryp, UMR 17, CIRAD, Montpellier, France.; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Center, Seattle, WA, USA.",N/A
40375301,Perioperative nivolumab and chemotherapy in locally advanced squamous cell carcinoma of the oesophagus: a randomized multicentre phase 2 study with circulating tumor DNA dynamics monitoring.,2025,"Peng Cui, Jingshu Wang, Xuning Fan, Fujun Qiu, Chengcheng Li, Guoqiang Wang, Zhihong Zhang, Shangli Cai","Burning Rock Biotech, Guangdong, China.",N/A
40373109,A combined risk model shows viability for personalized breast cancer risk assessment in the Indonesian population: A case/control study.,2025,"Bijak Rabbani, Sabrina Gabriel Tanu, Kevin Nathanael Ramanto, Jessica Audrienna, Eric Aria Fernandez, Fatma Aldila, Mar Gonzalez-Porta, Margareta Deidre Valeska, Jessline Haruman, Lorina Handayani Ulag, Yusuf Maulana, Kathleen Irena Junusmin, Margareta Amelia, Gabriella Gabriella, Feilicia Soetyono, Aulian Fajarrahman, Salma Syahfani Maudina Hasan, Levana Sani, Astrid Irwanto","PT Nalagenetik Riset Indonesia, Jakarta, Indonesia.; Nalagenetics Pte Ltd, Lower Delta Road, #04-05/06/07/08, Singapore.",N/A
40367191,MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson's disease.,2025,Yongfeng Chen,"Hangzhou Attec Biotech Co. Ltd., Room 406-409, Building 2, 1299 Zhangheng Road, Shanghai, China.",N/A
40364850,Summarizing clinical evidence utilizing large language models for cancer treatments: a blinded comparative analysis.,2025,"Rahul Banerjee, Will Ma, Mary Kwok, Andrew J Cowan","Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA, United States.; Hope AI, Inc, Princeton, NJ, United States.",N/A
40360636,An epimer of threose nucleic acid enhances oligonucleotide exonuclease resistance through end capping.,2025,Chunlei Zhang,"Gingko Biotech Limited, Hong Kong SAR, 000000, China.",N/A
40360497,Clinical response to azacitidine in MDS is associated with distinct DNA methylation changes in HSPCs.,2025,"Chun Y Fong, Kevin J Spring, Dirk Hoenemann","South-West Sydney Clinical Campuses, UNSW Medicine & Health, Sydney, NSW, Australia.; Department of Haematology, Austin Health, Melbourne, VIC, Australia.; Otway Pharmaceutical Development and Consulting Pty Ltd, Forrest, VIC, Australia.",N/A
40346041,"Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer.",2025,"Xueping Qu, Habib Hamidi, Radia M Johnson, Ethan S Sokol, Eva Lin, Cathy Eng, Smruthy Sivakumar, Benjamin Kaplan, Felipe de Sousa E Melo, Andrew Mancini, Matthew Wongchenko, Yi Shi, David Shames, Yibing Yan, Fortunato Ciardiello, Carlos Bais","Foundation Medicine, Inc, Boston, MA, USA.; Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.; Genentech, Inc, South San Francisco, CA, USA. baiscarlos@gmail.com.; Genentech, Inc, South San Francisco, CA, USA.; MD Anderson Cancer Center, Houston, TX, USA.",baiscarlos@gmail.com
40340441,Overall survival in patients with metastatic castration-sensitive prostate cancer treated with apalutamide versus abiraterone acetate: a head-to-head analysis of real-world patients in the USA.,2025,"Benjamin Lowentritt, Ibrahim Khilfeh, Carmine Rossi, Shawn Du, Frederic Kinkead, Lilian Diaz, Dominic Pilon, Lorie Ellis, Neal D Shore","Johnson & Johnson, Horsham, PA 19044, USA.; Analysis Group, Inc., Montréal, QC H3B 0G7, Canada.; Carolina Urologic Research Center, Myrtle Beach, SC 29572, USA.; Chesapeake Urology, Towson, MD 21204, USA.",N/A
40338593,Detection and Characterization of RB1 Mosaicism in Patients With Retinoblastoma Receiving cfDNA Test.,2025,"Melissa Robbins, Danielle N Friedman, Jennifer Kennedy, Elise Fiala, Ira J Dunkel, Jasmine H Francis, Jorge S Reis-Filho, David H Abramson","Cancer Biomarker Development, Oncology Research and Development, AstraZeneca, Gaithersburg, Maryland.; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Ophthalmology, Weill Cornell Medical Center, New York, New York.",N/A
40334315,Durvalumab with or without tremelimumab in combination with chemotherapy in first-line metastatic non-small-cell lung cancer: outcomes by tumor mutational burden in POSEIDON.,2025,"K S Oliner, A L'Hernault, M Ratcliffe, H Madison, Z Lai, R Stewart, H Mann, C Lowery","AstraZeneca, Gaithersburg, USA.; AstraZeneca, Waltham, USA.; AstraZeneca, Cambridge, UK.",N/A
40333756,Cyclic peptide inhibitors function as molecular glues to stabilize Gq/11 heterotrimers.,2025,"Ramon Guixà-González, Fabio Andres, Arianna Bacchin, Michael Hennig, Xavier Deupi","Condensed Matter Theory Group, PSI Center for Scientific Computing, Theory and Data, Villigen 5232, Switzerland.; LeadXpro AG, Park Innovaare, Villigen 5234, Switzerland.",N/A
40328426,The 2025 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of esophageal and gastroesophageal junction cancer.,2025,"Daniela Molena, Marisa Sewell, Steve B Maron, Peter C Enzinger, Hans Gerdes, Smita Sihag","Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Gastroenterology, Hepatology, and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: molenad@mskcc.org.; Center for Esophageal and Gastric Cancer, Dana Farber/Brigham Cancer Center, Boston, Mass.",molenad@mskcc.org
40318657,Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer.,2025,"Fábio Cardoso Borges, Robbe Saesen, Thierry Gorlia, Frank Hulstaert, Isabelle Huys, Paul Kluetz, Michael J Morris, Andrew Thomson, Denis Lacombe","Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; European Medicines Agency, Amsterdam, Netherlands.; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium; Clinical Pharmacology and Pharmacotherapy Research Unit, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. Electronic address: fabio.borges@eortc.org.; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium; Clinical Pharmacology and Pharmacotherapy Research Unit, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.; European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.; Belgian Health Care Knowledge Centre (KCE), Brussels, Belgium.; Clinical Pharmacology and Pharmacotherapy Research Unit, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.",fabio.borges@eortc.org
40317470,AI-Driven ,2025,"Eduardo González García, Pablo Varas, Pedro González-Naranjo, Eugenia Ulzurrun, Guillermo Marcos-Ayuso, Concepción Pérez, Juan A Páez, David Rios Insua, Simón Rodríguez Santana, Nuria E Campillo","Universidad Pontificia Comillas (ICAI) - IIT. C/Alberto Aguilera, 25, 28015 Madrid, Spain.; AItenea Biotech S.L., C/Alfonso XII, 46, 28014 Madrid, Spain.; Centro de Investigaciones Biológicas Margarita Salas (CIB Margarita Salas-CSIC). C/Ramiro de Maeztu, 9, 28040 Madrid, Spain.; Instituto de Ciencias Matemáticas (ICMAT-CSIC), C/Nicolás Cabrera, 13-15, 28049 Madrid, Spain.; Instituto de Química Médica (IQM-CSIC). C/Juan de la Cierva, 3, 28006 Madrid, Spain.",N/A
40316348,"A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours.",2025,"Sant P Chawla, Jose G Monzon, Mun Hui, Kejia Wang, Antreas Hindoyan, Weibing Shi, Hansen Wong, Mira Kistler","Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.; Amgen Inc San Francisco, South San Francisco, California, USA.; Amgen, Thousand Oaks, California, USA.; Sarcoma Oncology Center, Santa Monica, California, USA.; Tom Baker Cancer Centre, Calgary, Alberta, Canada.",N/A
40313979,"Discovery, design, and engineering of enzymes based on molecular retrobiosynthesis.",2025,"Ancheng Chen, Xiangda Peng, Tao Shen, Liangzhen Zheng, Dong Wu, Sheng Wang",Shanghai Zelixir Biotech Company Ltd. Shanghai China.,N/A
40307269,Molecular dynamics simulation and docking studies reveals inhibition of NF-kB signaling as a promising therapeutic drug target for reduction in cytokines storms.,2025,"Abhishek Kumar, Tharun Bharadwaj, Likith Muthuraj, Jitendra Kumar, Pravin Kumar, Roopa Lalitha, Gladstone Sigamani, Shaban Ahmad, Piyush Bhanu","International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067, India.; Department of Computational Biology and AI, Kcat Enzymatic Private Limited, #16, Ramakrishnappa Road, Cox Town, Bangalore, 560005, India. pravin.k@kcat.co.in.; Department of Computational Biology and AI, Kcat Enzymatic Private Limited, #16, Ramakrishnappa Road, Cox Town, Bangalore, 560005, India.; Biotechnology Industry Research Assistance Council (BIRAC), NSIC Business Park, NSIC Bhawan, Okhla Industrial Estate, New Delhi, 110020, India. md.birac@nic.in.; Xome Life Sciences, Bangalore Bioinnovation Center, Helix Biotech Park, Bangalore, 560100, India.",pravin.k@kcat.co.in
40303903,AlphaMissenseR: an integrated framework for investigating missense mutations in human protein-coding genes.,2025,Martin Morgan,"Roswell Park Comprehensive Cancer Center, Buffalo, NY 14221, United States.",N/A
40301557,D3S-001 in advanced solid tumors with KRAS,2025,"Cheng Chen, Jia Wang, Yandong Shen, Zifei Fan, Qian Chen, Hui Wang, Jing Zhang, Zhi Jian Chen","D3 Bio Inc., Shanghai, China.",N/A
40298994,"Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia.",2025,"Anna Turkina, Olga Vinogradova, Elza Lomaia, Oleg Shukhov, Ekaterina Chelysheva, Irina Nemchenko, Anna Petrova, Anastasiya Bykova, Nadiya Siordiya, Vasily Shuvaev, Ilya Mikhailov, Ghermes Chilov","Fusion Pharma, Nobelya st. 5, Moscow, 121205, Russian Federation. ghermes@fusion-pharma.com.; Russian Medical Academy of Postgraduate Education, Moscow, Russia.; Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.; Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation.; Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation, Moscow, Russia.; National Medical Research Center for Haematology, Moscow, Russian Federation.; A.Tsyb Medical Radiological Research Center, Obninsk, Russian Federation.",ghermes@fusion-pharma.com
40297626,TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer.,2025,"Joyce O'Shaughnessy, Massimo Cristofanilli, Sherene Loi, David W Cescon, Tina Hovey, Agata Nawrot, Karson Tse, Petra Vukovic","Texas Oncology, Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA.; Oncology R&D, AstraZeneca, Cambridge, UK.; Department of Medical Oncology, Princess Margaret Cancer Centre/UHN, Toronto, ON, Canada.; Biostatistics, Phastar UK (under contract to AstraZeneca), London, UK.; Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Oncology R&D, AstraZeneca, Warsaw, Poland.",N/A
40294008,Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations.,2025,"Michelangelo Marasco, Dinesh Kumar, Riccardo Mezzadra, Wei Luan, Radha Mukherjee, Ilinca Aricescu, Vladimir Markov, Yuxin Zhu, Elisa de Stanchina, Scott W Lowe, Rona Yaeger, Neal Rosen","Antitumour Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York.; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York.",N/A
40290879,Nanoscale piezoelectric patches preserve electrical integrity of infarcted hearts.,2025,"Luís M Monteiro, Francisco Vasques-Nóvoa, Rita N Gomes, Leonardo Ricotti, Lorenzo Vannozzi, Daniele Guarnera, Perpétua Pinto-do-Ó, Diana S Nascimento","ICBAS - Instituto de Ciências Biomédicas de Abel Salazar, Universidade do Porto, Porto, Portugal.; INEB - Instituto Nacional de Engenharia Biomédica, Universidade do Porto, Porto, Portugal.; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; Department of Excellence in Robotics & AI, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33, 56127, Pisa, Italy.",N/A
40290585,Quantifying the Unknowns of Plaque Morphology: The Role of Topological Uncertainty in Coronary Artery Disease.,2025,"Yashbir Singh, Bradley Erickson, Francisco Lopez-Jimenez","Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.; Department of Radiology, Mayo Clinic, Rochester, MN.",N/A
40290517,Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis.,2025,"Kornelius Schulze, Lorenz Adlung, Thorben W Fründt, Ansgar W Lohse, Samuel Huber, Bruno Sangro, Jesus M Banales, Henning Wege, Johann von Felden","ERN-RARE-LIVER, Hamburg, Germany.; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.; Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.; Hamburg Center for Translational Immunology (HCTI), and Center for Biomedical AI (bAIome), Hamburg, Germany.",N/A
40288083,Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels.,2025,"Danielle Duffy, Gaya Anschuetz, Bronwyn A Kingwell, Robert A Harrington","CSL Behring, King of Prussia, Pennsylvania, USA.; CSL Limited, Melbourne, Australia.; Weill Cornell Medicine, New York, New York, USA.",N/A
40283347,"Seeking Solutions for Inclusively Economic, Rapid, and Safe Molecular Detection of Respiratory Infectious Diseases: Comprehensive Review from Polymerase Chain Reaction Techniques to Amplification-Free Biosensing.",2025,Yaping Xie,"Sansure Biotech Inc., Changsha 410205, China.",N/A
40281056,A promptable CT foundation model for solid tumor evaluation.,2025,"Léo Machado, Léo Alberge, Hélène Philippe, Elodie Ferreres, Julien Khlaut, Julie Dupuis, Korentin Le Floch, Denis Habip Gatenyo, Pascal Roux, Jules Grégory, Maxime Ronot, Corentin Dancette, Tom Boeken, Daniel Tordjman, Pierre Manceron, Paul Hérent","Université Paris Cité, Paris, France. maxime.ronot@aphp.fr.; Centre d'Imagerie du Nord, Saint-Denis, France.; Raidium, Paris Biotech Santé, Paris, France.; Department of Radiology, Hôpital Cochin, AP-HP, Paris, France.; Université Paris Cité, Paris, France.; Department of Vascular and Oncological Interventional Radiology, Université Paris Cité, AP-HP, Hôpital Européen Georges Pompidou, HEKA INRIA, Paris, France.",maxime.ronot@aphp.fr
40280867,Associations between early tumor shrinkage/depth of response and survival from the ARCAD database.,2025,"Kentaro Yamazaki, Jean-Yves Douillard, Qian Shi","Medical Oncology Department, Integrated Centers for Oncology Nantes, Nantes, France.; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.; Department of Quantitative Science Research, Mayo Clinic, Rochester, MN, United States.",N/A
40275401,Biomanufacturing and lipidomics analysis of extracellular vesicles secreted by human blood vessel organoids in a vertical wheel bioreactor.,2025,Sunghoon Jung,"PBS Biotech Inc, CA, 93012, USA.",N/A
40271639,Barriers to publishing early phase clinical trials: the oncologists' perspective.,2025,"Pedro Bergmann, Ignacio Melero, Emiliano Calvo, Philippe A Cassier, Alexander Drilon, Juanita Lopez, Anna Minchom, Johann S De Bono","Clinica Universidad de Navarra, CIMA and CIBERONC, Pamplona 31008, Spain.; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid 28050, Spain.; The Royal Marsden NHS Foundation Trust, London SW3 6JJ, United Kingdom.; Centre Léon Bérard, Lyon 69008, France.; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center, New York, NY 10065, United States.",N/A
40266224,An mRNA Vaccine for Herpes Zoster and Its Efficacy Evaluation in Naïve/Primed Murine Models.,2025,"Linglei Jiang, Wenshuo Zhou, Fei Liu, Wenhui Li, Yan Xu, Zhenwei Liang, Man Cao, Li Hou, Pengxuan Liu, Feifei Wu, Aijun Shen, Zhiyuan Zhang, Xiaodi Zhang, Haibo Zhao, Xinping Pan, Tengjie Wu, William Jia, Yuntao Zhang","Sinopharm Group China National Biotech Group (CNBG) Co., Ltd., Beijing 100124, China.; CNBG-Virogin Biotech (Shanghai) Co., Ltd., Shanghai 201800, China.; Shanghai-Virogin Biotech Co., Ltd., Shanghai 201800, China.",N/A
40250867,"Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v.",2025,"Hana Matuskova, Pavel Marasek, Ekaterina Simonova, Lucie Kosinova, Petr Danek, Klara Danova, Katerina Sajnerova, Iva Malatova, Klara Hrabankova, Denise Greco, Ondrej Martinec, Matej Fabisik, Nada Podzimkova, Kamila Hladikova, Zuzana Antosova, David Béchard, Ulrich Moebius, Lenka Palova Jelinkova, Radek Spisek, Martin Steegmaier, Irena Adkins","SOTIO Biotech a.s, Prague, Czech Republic.; Cytune Pharma S.A.S, Nantes, France.; SOTIO Biotech a.s, Prague, Czech Republic adkins@sotio.com.",adkins@sotio.com
40246579,CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy.,2025,Boris Engels,"Miltenyi Biotec BV & Co KG, Bergisch Gladbach, Germany.",N/A
